
-
1998
Company Description
Noxxon Pharma develops biostable aptamers and substances based on mirror image nucleic acids.
NOXXON Pharma AG, a biopharmaceutical company, develops biostable aptamers and substances based on mirror image nucleic acids. Its Spiegelmer is a mirror image oligonucleotide therapeutic for the pharmacologically relevant target. The company has a strategic alliance with Pfizer, Inc. NOXXON Pharma AG was founded in 1997 and is based in Berlin, Germany.
-
Manufacturer:
Science and Engineering -
Formed:
1998 -
Company Website:
-
Company E-mail:
-
Company Address:
Max-Dohrn-Str. 8-10BerlinGermany -
CEO:
- Frank Morich
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits